Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Simes RJ (1986) Publication bias: the case for an international registry of clinical trials. J Clin Oncol 4: 1529–1541
Chalmers I (1990) Underreporting research is scientific misconduct. JAMA 263: 1405–1408
Davidoff F, DeAngelis CD, Drazen JM et al (2001) Sponsorship, authorship, and accountability. N Engl J Med 345: 825–826
Office of the New York State Attorney General Eliot Spitzer. Major pharmaceutical firm concealed information. Available at http://www.oag.state.ny.us/press/2004/jun/jun2b_04.html (Accessed 17 March 2005)
GlaxoSmithKline Clinical Trial register. Available at http;//ctr.gsk.co.uk/welcome.asp (Accessed 23 March 2005)
Merck. Merck announces voluntary worldwide withdrawal of VIOXX. September 30, 2004. Available at http://www.merck.co.vioxx_withdrawl/pdf/vioxx_press_release_final.pdf (Accessed 13 April 2006)
Gregory D, Curfman GD, Morrissey S, Drazen JM (2005) Expression of concern: Bombardier et al., “Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis” N Engl J Med 353: 2813–2814
Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343: 1520–1528
Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364: 2021–2029
Bombardier C, Laine L, Burgos-Vargas R et al (2006) Response to expression of concern regarding VIGOR study. N Engl J Med 354: 1196–1199
Silverstein FE, Faich G, Goldstein JL et al (2000) for the Celecoxib Long-Term Arthritis Safety Study. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 284: 1247–1255
Solomon SD, McMurray JJ, Pfeffer MA et al (2005) Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352: 1071–1080
Hrackovec JB, Mora M. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. JAMA 386: 2398
Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954–959
Pitt B, Pepine C, Willerson JT. Cyclooxygenase-2 inhibition and cardiovascular events. Circulation 106: 167–169
Mamdani M, Rochon P, Juurlink DN et al (2003) Effect of selective cyclooxygenase-2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med 163: 481–486
Solomon DH, Schneesweiss S, Glynn RJ et al (2004) Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109: 2068–2073
Graham DJ, Campen D, Hui R et al (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365: 475–481
Eckert CH. Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom. JAMA 277: 1200–1201
Rennie D (1997) Thyroid storm. JAMA 277: 1238–1243
Spigelman MK. Bioequivalence of levothyroxine preparations for treatment of hypothyroidism. JAMA 277: 1199–1200
Weiss RB, Rifkin RM, Stewart FM et al (2000) High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study. Lancet 355: 999–1003
Weiss RB, Gill CG, Hudis CA (2001) An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications. J Clin Oncol 19: 2771–2777
European Commission. Enterprise an Industry Directorate-General. Guideline on the data fields from the European clinical trials database (EudraCT) that may be included in the European data base on Medicinal Products. Available at: http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2005/03_05/Draft_guid_EudraCT_data_20050303.pdf (Accessed 17 March 2005)
United States Food and Drug Administration. Section 113 Food and Drug Administration Modernization Act of 1997. Available at: http://lhncbc.nlm.nih.gov/clin/113.html (Accessed 8 February 2006)
Fair Access to Clinical Trials Act of 2004, US Senate, S 2933, 108th Congress, Second Session. Available at: http://www.govtrack.us/data/us/bills.text/108/s2933.pdf (Accessed 9 February 2006)
Fair Access to Clinical Trials Act of 2004, House of Representatives, HR 5252, 108th Congress, Second Session. Available at: http://www.govtrack.us/data/us/bills.text/108/h5252.pdf (Accessed 9 February 2006)
Virginia. HB 2831/SB 1278. Publication of clinical trial results. Available at http://leg1.state.va.us/cgi-bin/legp504.exe?051+ful+CHAP0199 (Accessed 6 April 2006)
Maine. Governor’s Office of Health Policy and Finance. An Act Regarding Advertising by Drug Manufacturers and Disclosure of Clinical Trials. Available at http://www.maine.gov/dhhs (Accessed 5 April 2006)
De Angelis C, Drazen JM, Frizelle FA et al (2004) Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 292: 1363–1364
De Angelis C, Drazen JM, Frizelle FA, et al (2004) Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. JAMA 293: 2927–2929
Abbasi K (2004) Compulsory registration of clinical trials. BMJ 329: 637–638
Pharmaceutical Research and Manufacturer’s Association. PhRMA adopts principles for conduct of clinical trials and communication of clinical trial results. Available at: http://www.phrma.org/mediaroom/press/releases/20.06.2002.427.cfm (Accessed 28 May 2003)
Pharmaceutical Research and Manufacturer’s Association. Pharmaceutical companies to make more information available about clinical trials. Available at http://www.phrma.org/mediaroom/press/releases/06.01.2005.1112.cfm (Accessed 13 March 2005)
Pharmaceutical Research and Manufacturer’s Association. International alliance of pharmaceutical associations agrees on principles for disclosing information Available at http://www.phrma.org/mediaroom/press/releases/06.01.2005.1114.cfm (Accessed 13 March 2005)
Bennett NL, Casebeer LL, Kristofeo RE, Strasser SM (2004) Physicians’ Internet information-seeking behaviors. J Conting Ed Health Profess 24: 31–38
Lee J (2004) The power of negative thinking. Can J Emerg Med 6: 359–361
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Foote, M. (2006). Clinical trial registries and publication of results — a primer. In: Foote, M. (eds) Clinical Trial Registries. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-7583-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-7643-7583-6_1
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7578-2
Online ISBN: 978-3-7643-7583-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)